Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993601145> ?p ?o ?g. }
- W1993601145 endingPage "12" @default.
- W1993601145 startingPage "7" @default.
- W1993601145 abstract "Acute ischemic stroke (AIS) is a major cause of morbidity and mortality in the aging population worldwide. Alteplase, a recombinant tissue plasminogen activator, is the only Food and Drug Administration-approved thrombolytic agent for the treatment of AIS. Only 2-5% of patients with stroke receive thrombolytic treatment, mainly due to delay in reaching the hospital. Edaravone is a free radical scavenger marketed in Japan to treat patients with AIS, who present within 24 h of the onset of symptoms. When used in combination with alteplase, edaravone may have three useful effects: enhancement of early recanalization, inhibition of alteplase-induced hemorrhagic transformation and extension of the therapeutic time window for alteplase. This is the first review of the literature evaluating the clinical efficacy of edaravone, aiming to clarify whether edaravone should be further evaluated for clinical use worldwide. This review covers both clinical and experimental studies conducted between 1994 and 2012. Edaravone is a potentially useful neurovascular protective agent, used in combination with thrombolytic agents to treat >15 million patients devastated by stroke worldwide annually. Additional clinical studies are necessary to verify the efficacy of edaravone when used in combination with a thrombolytic agent." @default.
- W1993601145 created "2016-06-24" @default.
- W1993601145 creator A5002168194 @default.
- W1993601145 creator A5007399417 @default.
- W1993601145 creator A5015273720 @default.
- W1993601145 creator A5023336948 @default.
- W1993601145 creator A5034718955 @default.
- W1993601145 creator A5055576629 @default.
- W1993601145 creator A5071598217 @default.
- W1993601145 date "2012-08-29" @default.
- W1993601145 modified "2023-09-28" @default.
- W1993601145 title "Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke" @default.
- W1993601145 cites W1494500191 @default.
- W1993601145 cites W1509371197 @default.
- W1993601145 cites W1575484475 @default.
- W1993601145 cites W186716551 @default.
- W1993601145 cites W1966191289 @default.
- W1993601145 cites W1969909530 @default.
- W1993601145 cites W1972753581 @default.
- W1993601145 cites W1972869299 @default.
- W1993601145 cites W1981881424 @default.
- W1993601145 cites W1992112631 @default.
- W1993601145 cites W1993193194 @default.
- W1993601145 cites W1993454392 @default.
- W1993601145 cites W1997064745 @default.
- W1993601145 cites W1998250344 @default.
- W1993601145 cites W2003873084 @default.
- W1993601145 cites W2004287928 @default.
- W1993601145 cites W2012940535 @default.
- W1993601145 cites W2015183453 @default.
- W1993601145 cites W2018156750 @default.
- W1993601145 cites W2028398543 @default.
- W1993601145 cites W2043022038 @default.
- W1993601145 cites W2045994168 @default.
- W1993601145 cites W2046629096 @default.
- W1993601145 cites W2050302630 @default.
- W1993601145 cites W2051792050 @default.
- W1993601145 cites W2054361126 @default.
- W1993601145 cites W2059395281 @default.
- W1993601145 cites W2060638129 @default.
- W1993601145 cites W2074270552 @default.
- W1993601145 cites W2076675239 @default.
- W1993601145 cites W2082497790 @default.
- W1993601145 cites W2082665716 @default.
- W1993601145 cites W2082794414 @default.
- W1993601145 cites W2083511256 @default.
- W1993601145 cites W2092739280 @default.
- W1993601145 cites W2097084078 @default.
- W1993601145 cites W2099427033 @default.
- W1993601145 cites W2116222748 @default.
- W1993601145 cites W2129357435 @default.
- W1993601145 cites W2132305654 @default.
- W1993601145 cites W2134672868 @default.
- W1993601145 cites W2135637406 @default.
- W1993601145 cites W2136280619 @default.
- W1993601145 cites W2137708942 @default.
- W1993601145 cites W2142775251 @default.
- W1993601145 cites W2148207944 @default.
- W1993601145 cites W2153878657 @default.
- W1993601145 cites W2159233098 @default.
- W1993601145 cites W2159424186 @default.
- W1993601145 cites W2164077601 @default.
- W1993601145 cites W2164763924 @default.
- W1993601145 cites W2170230475 @default.
- W1993601145 cites W2180318774 @default.
- W1993601145 cites W2188308812 @default.
- W1993601145 cites W2292308933 @default.
- W1993601145 cites W2327025416 @default.
- W1993601145 cites W2531503442 @default.
- W1993601145 cites W2594075545 @default.
- W1993601145 cites W4250104750 @default.
- W1993601145 cites W4252401233 @default.
- W1993601145 cites W4256345024 @default.
- W1993601145 doi "https://doi.org/10.3892/br.2012.7" @default.
- W1993601145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3956767" @default.
- W1993601145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24648884" @default.
- W1993601145 hasPublicationYear "2012" @default.
- W1993601145 type Work @default.
- W1993601145 sameAs 1993601145 @default.
- W1993601145 citedByCount "36" @default.
- W1993601145 countsByYear W19936011452013 @default.
- W1993601145 countsByYear W19936011452014 @default.
- W1993601145 countsByYear W19936011452015 @default.
- W1993601145 countsByYear W19936011452016 @default.
- W1993601145 countsByYear W19936011452017 @default.
- W1993601145 countsByYear W19936011452018 @default.
- W1993601145 countsByYear W19936011452019 @default.
- W1993601145 countsByYear W19936011452020 @default.
- W1993601145 countsByYear W19936011452021 @default.
- W1993601145 countsByYear W19936011452022 @default.
- W1993601145 countsByYear W19936011452023 @default.
- W1993601145 crossrefType "journal-article" @default.
- W1993601145 hasAuthorship W1993601145A5002168194 @default.
- W1993601145 hasAuthorship W1993601145A5007399417 @default.
- W1993601145 hasAuthorship W1993601145A5015273720 @default.
- W1993601145 hasAuthorship W1993601145A5023336948 @default.
- W1993601145 hasAuthorship W1993601145A5034718955 @default.
- W1993601145 hasAuthorship W1993601145A5055576629 @default.